Qube Research & Technologies (QRT)’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Sell |
438,026
-504,865
| -54% | -$3.24M | ﹤0.01% | 1475 |
|
|
2025
Q1 | $3.34M | Buy |
942,891
+162,325
| +21% | +$575K | ﹤0.01% | 1367 |
|
|
2024
Q4 | $2.95M | Buy |
780,566
+596,672
| +324% | +$2.26M | ﹤0.01% | 1359 |
|
|
2024
Q3 | $596K | Sell |
183,894
-605,233
| -77% | -$1.96M | ﹤0.01% | 1826 |
|
|
2024
Q2 | $1.5M | Sell |
789,127
-154,936
| -16% | -$294K | ﹤0.01% | 1470 |
|
|
2024
Q1 | $2.68M | Buy |
944,063
+461,464
| +96% | +$1.31M | ﹤0.01% | 1354 |
|
|
2023
Q4 | $7.1M | Buy |
482,599
+319,889
| +197% | +$4.71M | 0.01% | 726 |
|
|
2023
Q3 | $2.98M | Buy |
162,710
+38,530
| +31% | +$705K | 0.01% | 946 |
|
|
2023
Q2 | $2.68M | Buy |
124,180
+92,455
| +291% | +$1.99M | 0.01% | 860 |
|
|
2023
Q1 | $931K | Buy |
+31,725
| New | +$931K | ﹤0.01% | 1258 |
|